Distinct roles for p53 transactivation and repression in preventing UCN-01-mediated abrogation of DNA damage-induced arrest at S and G2 cell cycle checkpoints
Authors:
- 14 March 2005
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 24 (23) , 3786-3796
Abstract
The topoisomerase I inhibitor SN38 arrests cell cycle progression primarily in S or G2 phases of the cell cycle in a p53-independent manner. The Chk1 inhibitor, 7-hydroxystaurosporine (UCN-01), overcomes both S and G2 arrest preferentially in cells mutated for p53, driving cells through a lethal mitosis and thereby enhancing cytotoxicity. The mechanism by which p53 maintains S and G2 arrest was investigated here. The p53 wild-type MCF10A cells were arrested in S phase by incubation with SN38 for 24 h. Subsequent incubation with UCN-01 failed to abrogate arrest. To examine the impact of p53, MCF10A cells were developed, which express the tetramerization domain of p53 to inhibit endogenous p53 function. These cells were attenuated in SN38-mediated induction of p21WAF1, and UCN-01 induced S, but not G2 progression. In contrast, MCF10A cells expressing short hairpin RNA to ablate p53 expression underwent both S and G2 phase progression with UCN-01. The difference in G2 progression was attributed to p53-mediated gene repression; the MCF10A cells expressing the tetramerization domain retained p53 protein and repressed both cyclin B and Chk1, while cells ablated for p53 did not repress these proteins. Hence, inhibition of p53 activator function permits S phase abrogation, while additional inhibition of p53 repressor function is required for abrogation of G2 arrest. These studies provide a mechanistic explanation for how this therapeutic strategy can selectively target tumor cells.Keywords
This publication has 29 references indexed in Scilit:
- Abrogation of the S Phase DNA Damage Checkpoint Results in S Phase Progression or Premature Mitosis Depending on the Concentration of 7-Hydroxystaurosporine and the Kinetics of Cdc25C ActivationJournal of Biological Chemistry, 2002
- Transcriptional Repression by p53 through Direct Binding to a Novel DNA ElementJournal of Biological Chemistry, 2001
- Retinoic acid activates p53 in human embryonal carcinoma through retinoid receptor-dependent stimulation of p53 transactivation functionOncogene, 2001
- DNA Damage Induces p53-dependent Down-regulation of hCHK1Journal of Biological Chemistry, 2001
- Rapid Destruction of Human Cdc25A in Response to DNA DamageScience, 2000
- Reciprocal Regulation via Protein-Protein Interaction between c-Myc and p21 in DNA Replication and TranscriptionJournal of Biological Chemistry, 2000
- Cyclin-dependent kinases at the G1-S transition of the mammalian cell cycle1Manuscript requested by Georg Krupitza and Akos Szakmary.1Mutation Research - Reviews in Mutation Research, 1999
- Regulation of p53 stability by Mdm2Nature, 1997
- Mdm2 promotes the rapid degradation of p53Nature, 1997
- p21 is a universal inhibitor of cyclin kinasesNature, 1993